By Scott Murdoch SYDNEY (Reuters) -Chinese drug developer Jiangsu Hengrui Pharmaceuticals has priced its stock offering on ...

By Scott Murdoch SYDNEY (Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals will price its shares ...

Singapore saw a significant increase in COVID-19 infections. The number of cases jumped from around 11,100 in the last week ...

COVID-19 cases are sharply increasing in parts of Asia, particularly Singapore and Hong Kong, driven by the fast-spreading ...

With total assets of $53.7 billion, FWD Group has launched its fourth IPO attempt in Hong Kong, tapping into surging investor ...

Health authorities in densely-populated Hong Kong and Singapore have warned that Covid-19 cases are spiking, as a resurgent ...

Several parts of Asia, like Hong Kong, Singapore, China and Thailand, are seeing a sharp surge in the number of coronavirus ...

At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore in the next 12 to 18 months, four sources said, as Chinese firms look to ...

Covid cases are rising again in parts of Southeast Asia, with Hong Kong and Singapore reporting a sudden spike. China and ...

India has remained largely unaffected by the recent surge in Covid cases, with the government maintaining that the situation ...

HONG KONG SAR - Media OutReach Newswire - - Mandarin Oriental, Hong Kong and LANDMARK are delighted to announce the ...

In response to growing global concerns over a surge in Covid-19 cases, a review meeting concluded that the situation in India ...